Human iPSC-Derived Lung Organoids are advanced 3D models created from human induced pluripotent stem cells (iPSCs) that replicate key aspects of lung structure and function. These organoids closely mimic the human lung, including alveolar cells, bronchiolar structures, and ciliated epithelial cells. They provide a physiologically relevant platform for studying lung development, respiratory diseases, and drug responses. These organoids are particularly valuable for investigating diseases such as asthma, COPD, and pulmonary fibrosis, offering insights into disease mechanisms and potential therapeutic targets. Compared to traditional 2D models, iPSC-derived lung organoids are a more accurate representation of the human lung microenvironment, enhancing the fidelity of disease modeling and drug testing. Organoids are rigorously tested for mycoplasma, bacteria, fungi/yeast, and verified for identity, genetic stability, and functional performance.
Embedded 3D Culture
All test negative for mycoplasma, bacteria, yeast, and fungi.
For research use only. iPSC-derived organoids are used in various research fields, including disease modeling, drug discovery, gene therapy evaluation, and personalized medicine. They can replicate diverse disease states, providing reliable platforms for studying neurodegenerative diseases, cancer and more. Additionally, organoids are valuable for drug efficacy and safety testing, tissue regeneration studies, and exploring host-microbe interactions, advancing innovation in biomedical research.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.